natgillin/translations-raw huggingface dataset:
OHSS may become a serious medical event characterised by large ovarian cysts which are prone to rupture, weight gain, dyspnoea, oliguria or the presence of ascites within a clinical picture of circulatory dysfunction.
Sindrom hiperstimulacije jajnika može postati ozbiljan medicinski slučaj karakteriziran velikim cistama jajnika sklonim rupturama, dobivanjem na tjelesnoj težini, dispneji, oliguriji i prisustvu ascitesa unutar kliničke slike poremećaja krvotoka.
OHSS may become severe with clearly enlarged ovaries, decreased urine production, weight gain, difficulty in breathing and/or possible fluid accumulation in your stomach or chest.
OHSS može postati težak s jasno povećanim jajnicima, smanjenim stvaranjem mokraće, povećanjem tjelesne težine, otežanim disanjem i/ili mogućim nakupljanjem tekućine u Vašem trbuhu ili prsištu.
OHSS may become severe with clearly enlarged ovaries, decreased urine production, weight gain, difficulty in breathing and/or possible fluid accumulation in your stomach or chest.
OHSS može postati težak uz jasno uvećane jajnike, smanjeno stvaranje urina, dobivanje na težini, poteškoće pri disanju i/ili s mogućim nakupljanjem tekućine u trbuhu ili prsnom košu.
OHSS may progress rapidly (within 24 hours) or over several days to become a serious medical event.
OHSS može brzo napredovati (unutar 24 sata) ili čak nekoliko dana te prerasti u ozbiljno medicinsko stanje.
OHSS occurs when the ovaries over-respond to treatment, causing abdominal swelling and pain, nausea and diarrhoea.
OHSS nastupa kada jajnici prekomjerno reagiraju na liječenje, što uzrokuje oteknuće želuca i bol, mučninu i proljev.
OIC symptom improvement
Poboljšanje simptoma konstipacije uzrokovane primjenom opioida
OIC was confirmed through a two week run in period and defined as < 3 spontaneous bowel movements (SBMs) per week on average with constipation symptoms associated with at least 25% of bowel movements.
Konstipacija uzrokovana primjenom opioida potvrđena je tijekom dvotjednog uvodnog razdoblja, a definirana je kao prosječno < 3 spontana pražnjenja crijeva na tjedan, uz prisutnost simptoma konstipacije kod najmanje 25% pražnjenja crijeva.
Oily spotting
Masna, uljasta stolica
Oily vehicle (vegetable oil).
Uljna pomoćna tvar (biljno ulje).
Oily vehicle (vegetable origin).
Uljna pomoćna tvar (biljnog podrijetla).
Ointment
Mast
Ointment.
Mast.
OL-LI 16 week
Otvorena uvodna – 16 tjedana
OL-LI 16 weeks
Otvorena uvodna – 16 tjedana
Olanzapine
olanzapin
Olanzapine 10 mg
Olanzapin 10 mg
Olanzapine 10 mg
Olanzapin 15 mg
Olanzapine 15 mg
Olanzapin 15 mg
Olanzapine 15 mg in Study D1050231, quetiapine extended-release (XR) 600 mg in Study D1050233.
Olanzapin 15 mg in Ispitivanju D1050231, kvetiapin s produljenim oslobađanjem (XR) 600 mg u ispitivanju D1050233.
Olanzapine 2.5 mg
Olanzapin 2,5 mg
Olanzapine 2.5 mg
Olanzapin 5 mg
Olanzapine 20 mg
Olanzapin 20 mg
Olanzapine 5 mg
Olanzapin 5 mg
Olanzapine 5 mg
Olanzapin 7,5 mg
Olanzapine 7.5 mg
Olanzapin 10 mg
Olanzapine 7.5 mg
Olanzapin 7,5 mg
Olanzapine administered with lithium or valproate resulted in increased levels ( 10 %) of tremor, dry mouth, increased appetite, and weight gain.
Olanzapin primijenjen s litijem ili valproatom rezultirao je povećanim razinama ( 10%) tremora, suhoće usta, povećanjem apetita i povećanjem tjelesne težine.
Olanzapine administered with lithium or valproate resulted in increased levels (10%) of tremor, dry mouth, increased appetite, and weight gain.
Davanje olanzapina s litijem ili valproatom rezultiralo je povećanom učestalošću ( 10%) tremora, suhoće usta, pojačanog teka i porasta tjelesne težine.
Olanzapine also demonstrated comparable efficacy results to haloperidol in terms of the proportion of patients in symptomatic remission from mania and depression at 6 and 12 weeks.
Olanzapin je također pokazao komparativne rezultate djelotvornosti u odnosu na haloperidol s obzirom na udio bolesnika koji su u 6. i 12. tjednu liječenja pokazali simptomatsku remisiju manije i depresije.
Olanzapine Apotex 10 mg are white, round biconvex film-coated tablets engraved ‘APO’ on one side and ‘OLA’ over ‘10’ on the other side.
Olanzapine Apotex tablete od 10 mg su okrugle, bikonveksne filmom obložene tablete s utisnutim »APO« na jednoj strani i »OLA« iznad »10« na drugoj.
Olanzapine Apotex 10 mg film-coated tablet
Olanzapine Apotex 10 mg filmom obložene tablete
Olanzapine Apotex 10 mg film-coated tablets
Olanzapine Apotex 10 mg filmom obložene tablete
Olanzapine Apotex 10 mg film-coated tablets olanzapine
Olanzapine Apotex 10 mg filmom obložene tablete olanzapin
Olanzapine Apotex 10 mg orodispersible tablet
Olanzapine Apotex 10 mg raspadljive tablete za usta
Olanzapine Apotex 10 mg orodispersible tablets
Olanzapine Apotex 10 mg raspadljive tablete za usta
Olanzapine Apotex 10 mg orodispersible tablets are yellow round flat faced radial edge tablets engraved ‘APO’ on one side and ‘OL’ over ‘10’ on the other side.
Olanzapine Apotex 10 mg raspadljive tablete za usta su žute, okrugle, plosnate sa radijalnim rubom i utisnutim »APO« na jednoj strani i »OL« iznad »10« na drugoj strani.
Olanzapine Apotex 10 mg orodispersible tablets olanzapine
Olanzapine Apotex 10 mg raspadljive tablete za usta olanzapin
Olanzapine Apotex 15 mg orodispersible tablet
Olanzapine Apotex 15 mg raspadljive tablete za usta
Olanzapine Apotex 15 mg orodispersible tablets
Olanzapine Apotex 15 mg raspadljive tablete za usta
Olanzapine Apotex 15 mg orodispersible tablets are available in blisters packs of 28 tablets.
Olanzapine Apotex raspadljive tablete za usta od 15 mg dostupne su u blister pakiranjima od 28 tableta.
Olanzapine Apotex 15 mg orodispersible tablets are yellow round flat faced radial edge tablets engraved ‘APO’ on one side and ‘OL’ over ‘15’ on the other side
Olanzapine Apotex 15 mg raspadljive tablete za usta su žute, okrugle, plosnate sa radijalnim rubom i utisnutim »APO« na jednoj strani i »OL« iznad »15« na drugoj strani.
Olanzapine Apotex 15 mg orodispersible tablets olanzapine
Olanzapine Apotex 15 mg raspadljive tablete za usta olanzapin
Olanzapine Apotex 2.5 mg are white, round, biconvex film-coated tablets engraved ‘APO’ on one side and ‘OLA’ over ‘2.5’ on the other side.
Olanzapine Apotex tablete od 2,5 mg su bijele, okrugle, bikonveksne filmom obložene tablete s utisnutim »APO« na jednoj strani i »OLA« iznad »2,5« na drugoj.
Olanzapine Apotex 2.5 mg film-coated tablet
Olanzapine Apotex 2,5 mg filmom obložene tablete
Olanzapine Apotex 2.5 mg film-coated tablets
Olanzapine Apotex 2,5 mg filmom obložene tablete
Olanzapine Apotex 2.5 mg film-coated tablets are available in blisters packs of 28 tablets.
Olanzapine Apotex 2,5 mg filmom obložene tablete dostupne su u blister pakiranjima od 28 tableta.
Olanzapine Apotex 2.5 mg film-coated tablets olanzapine
Olanzapine Apotex 2,5 mg filmom obložene tablete olanzapin
Olanzapine Apotex 20 mg orodispersible tablet
Olanzapine Apotex 20 mg raspadljive tablete za usta
Olanzapine Apotex 20 mg orodispersible tablets
Olanzapine Apotex 20 mg raspadljive tablete za usta
Olanzapine Apotex 20 mg orodispersible tablets are available in blister packs of 28 and 56 tablets.
Olanzapine Apotex raspadljive tablete za usta od 20 mg dostupne su u blister pakiranjima od 28 i 56 tableta.
Olanzapine Apotex 20 mg orodispersible tablets are yellow round flat faced radial edge tablets engraved ‘APO’ on one side and ‘OL’ over ‘20’ on the other side.
Olanzapine Apotex 20 mg raspadljive tablete za usta su žute, okrugle, plosnate sa radijalnim rubom i utisnutim »APO« na jednoj strani i »OL« iznad »20« na drugoj strani.
Olanzapine Apotex 20 mg orodispersible tablets olanzapine
Olanzapine Apotex 20 mg raspadljive tablete za usta olanzapin
Olanzapine Apotex 5 mg and 10 mg film- coated tablets are available in blister packs of 28, 56 and 98 tablets..
Olanzapine Apotex 5 mg i 10 mg filmom obložene tablete dostupne su u blister pakiranjima od 28, 56 i 98 tableta.
Olanzapine Apotex 5 mg and 10 mg orodispersible tablets are available in blisters packs of 28 , 56 and 98 tablets.
Olanzapine Apotex raspadljive tablete za usta od 5 mg i 10 mg dostupne su u blister pakiranjima od 28, 56 i 98 tableta.
Olanzapine Apotex 5 mg are white, round biconvex film-coated tablets engraved ‘APO’ on one side and ‘OLA’ over ‘5’ on the other side.
Olanzapine Apotex tablete od 5 mg su bijele, okrugle, bikonveksne filmom obložene tablete s utisnutim »APO« na jednoj strani i »OLA« iznad »5« na drugoj.
Olanzapine Apotex 5 mg film-coated tablet
Olanzapine Apotex 5 mg filmom obložene tablete
Olanzapine Apotex 5 mg film-coated tablets
Olanzapine Apotex 5 mg filmom obložene tablete
Olanzapine Apotex 5 mg film-coated tablets olanzapine
Olanzapine Apotex 5 mg filmom obložene tablete olanzapin
Olanzapine Apotex 5 mg orodispersible tablet
Olanzapine Apotex 5 mg raspadljive tablete za usta
Olanzapine Apotex 5 mg orodispersible tablets
Olanzapine Apotex 5 mg raspadljive tablete za usta
Olanzapine Apotex 5 mg orodispersible tablets are yellow round flat faced radial edge tablets engraved ‘APO’ on one side and ‘OL’ over ‘5’ on the other side.
Olanzapine Apotex 5 mg raspadljive tablete za usta su žute, okrugle, plosnate sa radijalnim rubom i utisnutim »APO« na jednoj strani i »OL« iznad »5« na drugoj strani.
Olanzapine Apotex 5 mg orodispersible tablets olanzapine
Olanzapine Apotex 5 mg raspadljive tablete za usta olanzapin
Olanzapine Apotex 5 mg orodispersible tablets Olanzapine Apotex 10 mg orodispersible tablets Olanzapine Apotex 15 mg orodispersible tablets Olanzapine Apotex 20 mg orodispersible tablets
Olanzapine Apotex 5 mg raspadljive tablete za usta Olanzapine Apotex 10 mg raspadljive tablete za usta Olanzapine Apotex 15 mg raspadljive tablete za usta Olanzapine Apotex 20 mg raspadljive tablete za usta olanzapin
Olanzapine Apotex 7.5 mg are white, round biconvex film-coated tablets engraved ‘APO’ on one side and ‘OLA’ over ‘7.5’ on the other side.
Olanzapine Apotex tablete od 7,5 mg su bijele, okrugle, bikonveksne filmom obložene tablete s utisnutim »APO« na jednoj strani i »OLA« iznad »7,5« na drugoj.
Olanzapine Apotex 7.5 mg film-coated tablet
Olanzapine Apotex 7,5 mg filmom obložene tablete
Olanzapine Apotex 7.5 mg film-coated tablets
Olanzapine Apotex 7,5 mg filmom obložene tablete
Olanzapine Apotex 7.5 mg film-coated tablets are available in blisters packs of 28 and 56 tablets.
Olanzapine Apotex 7,5 mg filmom obložene tablete dostupne su u blister pakiranjima od 28 i 56 tableta.
Olanzapine Apotex 7.5 mg film-coated tablets olanzapine
Olanzapine Apotex 7,5 mg filmom obložene tablete olanzapin
Olanzapine Apotex is not for patients who are under 18 years.
Olanzapine Apotex nije za primjenu u bolesnika mlađih od 18 godina.
Olanzapine Cipla 1 olanzapine
Olanzapine Cipla 1 olanzapin
Olanzapine Cipla 10 mg coated tablets
OLANZAPINE CIPLA 10 mg obložene tablete
Olanzapine Cipla 10 mg coated tablets are available in 7, 28 and 56 blister packs.
Olanzapin Cipla 10 mg obložene tablete su dostupne u 7 , 28 i 56 žulj paketima .
Olanzapine Cipla 10 mg coated tablets are white, round, biconvex, coated tablets with ‘OLZ 10’ debossed on one side and ‘NEO’ on the other.
Olanzapin Cipla 10 mg obložene tablete su bijele , okrugle, bikonveksne , obložene tablete s ' OLZ 10 ' debossed s jedne strane i " NEO " s druge strane.
Olanzapine Cipla 10 mg coated tablets olanzapine
OLANZAPINE CIPLA 10 mg obložene tablete olanzapin
Olanzapine Cipla 15 mg coated tablets
OLANZAPINE CIPLA 15 mg obložene tablete
Olanzapine Cipla 15 mg coated tablets are blue, elliptical, convex, coated tablets with ‘NEO’ debossed on one side and plain on the other side.
Olanzapin Cipla 15 mg obložene tablete su plave , eliptična , konveksna , obložene tablete s " NEO " debossed na jednoj strani i ravni i na drugoj strani .
Olanzapine Cipla 15 mg coated tablets olanzapine
OLANZAPINE CIPLA 15 mg obložene tablete olanzapin
Olanzapine Cipla 2.5 mg
OLANZAPINE CIPLA 2,5 mg
Olanzapine Cipla 2.5 mg coated tablets
OLANZAPINE CIPLA 2,5 mg obložene tablete
Olanzapine Cipla 2.5 mg coated tablets are white, round, biconvex, coated tablets with ‘2.5’ debossed on one side and ‘OLZ’ on the other.
Olanzapin Cipla 2,5 mg obložene tablete su bijele , okrugle, bikonveksne , obložene tablete s '2.5' debossed s jedne strane i ' OLZ ' nadruge.
Olanzapine Cipla 2.5 mg coated tablets olanzapine
OLANZAPINE CIPLA 2,5 mg obložene tablete olanzapin
Olanzapine Cipla 2.5 mg, 5 mg, 7.5 mg and 15 mg coated tablets are available in 28 and 56 blister packs.
Olanzapin Cipla 2,5 mg , 5 mg , 7,5 mg i 15 mg obložene tablete su dostupne u 28 i 56 blister omot .
Olanzapine Cipla 5 mg coated tablets
OLANZAPINE CIPLA 5 mg obložene tablete
Olanzapine Cipla 5 mg coated tablets are white, round, biconvex, coated tablets with ‘OLZ 5’ debossed on one side and ‘NEO’ on the other.
Olanzapin Cipla 5 mg obložene tablete su bijele , okrugle, bikonveksne , obložene tablete s ' OLZ 5 ' debossed s jedne strane i " NEO " s druge strane.
Olanzapine Cipla 5 mg coated tablets olanzapine
OLANZAPINE CIPLA 5 mg obložene tablete olanzapin
Olanzapine Cipla 7.5 mg
OLANZAPINE CIPLA 7,5 mg
Olanzapine Cipla 7.5 mg coated tablets
OLANZAPINE CIPLA 7,5 mg obložene tablete
Olanzapine Cipla 7.5 mg coated tablets olanzapine
OLANZAPINE CIPLA 7,5 mg obložene tablete olanzapin
OLANZAPINE CIPLA contains lactose.
OLANZAPINE CIPLA sadrži laktozu
Olanzapine Cipla is a medicine that contains the active substance olanzapine.
Olanzapine Cipla je lijek koji sadrži djelatnu tvar olanzapin.
Olanzapine Cipla is a ‘generic medicine’.
Olanzapine Cipla je „generički lijek”.
Olanzapine Cipla is also used to treat moderate to severe manic episodes (extremely high mood) in adults.
Olanzapine Cipla je indiciran za liječenje umjerenih do teških epizoda manije (ekstremno dobrog raspoloženja) u odraslih osoba.
OLANZAPINE CIPLA is not for patients who are under 18 years.
OLANZAPINE CIPLA nije za primjenu u bolesnika mlađih od 18 godina.
Olanzapine Cipla is used to treat adults with schizophrenia.
Olanzapine Cipla se koristi za liječenje shizofrenije u odraslih osoba.
OLANZAPINE CIPLA with alcohol
OLANZAPINE CIPLA s alkoholom
Olanzapine demonstrated a greater in vitro affinity for serotonin 5-HT2 than dopamine D2 receptors and greater 5- HT2 than D2 activity in vivo, models.
Olanzapin je in vitro iskazao veći afinitet za 5-HT2 serotoninske nego za D2 dopaminske receptore i veću aktivnost na 5-HT2 nego na D2 receptorima u in vivo modelima.
Olanzapine demonstrated a greater in vitro affinity for serotonin 5HT2 than dopamine D2 receptors and greater 5 HT2 than D2 activity in vivo models.
Olanzapin je in vitro pokazao veći afinitet za serotoninske 5HT2 nego dopaminske D2 receptore te veće djelovanje na 5HT2 nego D2 u in vivo modelima.
Olanzapine demonstrated a greater in vitro affinity for serotonin 5HT2 than dopamine D2 receptors and greater 5 HT2 than D2 activity in vivo, models.
Olanzapin je in vitro pokazao veći afinitet za serotoninske 5HT2 nego dopaminske D2 receptore te veće djelovanje na 5 HT2 nego D2 u in vivo modelima.
Olanzapine demonstrated a greater in vitro affinity for serotonin 5HT2 than dopamine D2 receptors and greater 5HT2 than D2 activity in vivo models.
Olanzapin je in vitro pokazao veći afinitet za serotoninske 5HT2 nego dopaminske D2 receptore te veće djelovanje na 5HT2 nego D2 u in vivo modelima.
Olanzapine demonstrated a greater in vitro affinity for serotonin 5HT2 than dopamine D2 receptors and greater 5HT2 than D2 activity in vivo, models.
Olanzapin je in vitro pokazao veći afinitet za serotoninske 5HT2 nego dopaminske D2 receptore te veće djelovanje na 5HT2 nego D2 u in vivo modelima.
Olanzapine demonstrated a greater in-vitro affinity for serotonin 5HT2 than dopamine D2 receptors and greater 5 HT2 than D2 activity in vivo models.
Olanzapin je in vitro pokazao veći afinitet za serotoninske 5HT2 nego dopaminske D2 receptore te veće djelovanje na 5HT2 nego D2 u in vivo modelima.
Olanzapine does not inhibit the main CYP450 isoenzymes in vitro (e.g.
Olanzapin in vitro ne inhibira glavne izoenzime CYP450 (npr.
Olanzapine does not inhibit the main CYP450 isoenzymes in vitro (e.g.
Olanzapin ne inhibira glavne izoenzime CYP450 in vitro (npr.
Olanzapine for injection should not be combined in a syringe with haloperidol injection because the resulting low pH has been shown to degrade olanzapine over time.
Olanzapin za injekciju ne smije se miješati u štrcaljki s haloperidolom za injekciju jer dolazi do snižavanja pH vrijednosti koja s vremenom razgrađuje olanzapin.
Olanzapine Glenmark 10 mg tablets Olanzapine
Olanzapin Glenmark 10 mg tablete olanzapin
Olanzapine Glenmark 10 mg: yellow coloured circular flat bevelled edge tablets with ‘OL’ debossed on one side and ‘4’ debossed on other side.
Olanzapin Glenmark 10 mg: žute, okrugle, plosnate tablete kosih rubova, s utisnutom oznakom ‘OL’ na jednoj i ‘4’ na drugoj strani.
Olanzapine Glenmark 15 mg tablets Olanzapine
Olanzapin Glenmark 15 mg tablete olanzapin
Olanzapine Glenmark 15 mg: yellow coloured circular flat bevelled edge tablets with ‘OL’ debossed on one side and ‘5’ debossed on other side.
Olanzapin Glenmark 15 mg: žute, okrugle, plosnate tablete kosih rubova, s utisnutom oznakom ‘OL’ na jednoj i ‘5’ na drugoj strani.
Olanzapine Glenmark 2.5 mg tablets Olanzapine
Olanzapin Glenmark 2,5 mg tablete olanzapin
Olanzapine Glenmark 2.5 mg tablets Olanzapine Glenmark 5 mg tablets Olanzapine Glenmark 7.5 mg tablets Olanzapine Glenmark 10 mg tablets Olanzapine Glenmark 15 mg tablets Olanzapine Glenmark 20 mg tablets
Olanzapin Glenmark 2,5 mg tablete Olanzapin Glenmark 5 mg tablete Olanzapin Glenmark 7,5 mg tablete Olanzapin Glenmark 10 mg tablete Olanzapin Glenmark 15 mg tablete Olanzapin Glenmark 20 mg tablete
Olanzapine Glenmark 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg are available in aluminium foil blisters of 28, 56, and 70 tablets
Olanzapin Glenmark 2,5 mg, 5 mg, 7,5 mg, 10 mg i 15 mg tablete dostupne su u blisterima od aluminijske folije s 28, 56 i 70 tableta.
Olanzapine Glenmark 2.5mg is supplied as: yellow coloured circular flat bevelled edge tablets with ‘1’ debossed on one side.
Olanzapin Glenmark 2,5 mg su dostupne kao: žute, okrugle, plosnate tablete kosih rubova, s utisnutom oznakom ‘1’ na jednoj strani.
Olanzapine Glenmark 20 mg tablets
Olanzapin Glenmark 20 mg tablete
Olanzapine Glenmark 20 mg tablets are available in aluminium foil blisters of 28, 35, 56 and 70 tablets
Olanzapin Glenmark 20 mg tablete dostupne su u blisterima od aluminijske folije s 28, 35, 56 i 70 tableta.
Olanzapine Glenmark 20 mg tablets Olanzapine
Olanzapin Glenmark 20 mg tablete olanzapin
Olanzapine Glenmark 20 mg: yellow coloured circular flat bevelled edge tablets with ‘OL’ debossed on one side and ‘6’ debossed on other side.
Olanzapin Glenmark 20 mg: žute, okrugle, plosnate tablete kosih rubova, s utisnutom oznakom ‘OL’ na jednoj i ‘6’ na drugoj strani.
Olanzapine Glenmark 5 mg tablets
Olanzapin Glenmark 5 mg tablete
Olanzapine Glenmark 5 mg tablets Olanzapine
Olanzapin Glenmark 5 mg tablete olanzapin
Olanzapine Glenmark 5 mg: yellow coloured circular flat bevelled edge tablets with ‘2’ debossed on one side.
Olanzapin Glenmark 5 mg: žute, okrugle, plosnate tablete kosih rubova, s utisnutom oznakom ‘2’ na jednoj strani.
Olanzapine Glenmark 7.5 mg tablets Olanzapine
Olanzapin Glenmark 7,5 mg tablete olanzapin
Olanzapine Glenmark 7.5 mg: yellow coloured circular flat bevelled edge tablets with ‘3’ debossed on one side.
Olanzapin Glenmark 7,5 mg: žute, okrugle, plosnate tablete kosih rubova, s utisnutom oznakom ‘3’ na jednoj strani.
Olanzapine Glenmark belongs to a group of medicines called antipsychotics.
Olanzapin Glenmark pripada skupini lijekova koji se zovu antipsihotici.
Olanzapine Glenmark contains a source of phenylalanine.
Olanzapin Glenmark sadrži izvor fenilalanina.
Olanzapine Glenmark contains aspartame
Olanzapin Glenmark sadrži aspartam
Olanzapine Glenmark contains the active substance olanzapine.
Olanzapin Glenmark sadrži djelatnu tvar olanzapin.
Olanzapine Glenmark Europe 10 mg orodispersible tablets
Olanzapin Glenmark Europe 10 mg raspadljive tablete za usta
Olanzapine Glenmark Europe 10 mg: yellow coloured circular flat bevelled edge orodispersible tablets with ‘OL’ debossed on one side and ‘4’ debossed on other side.
Olanzapin Glenmark Europe 10 mg: žute, okrugle, plosnate raspadljive tablete za usta kosih rubova, s utisnutom oznakom ‘OL’ na jednoj i ‘4’ na drugoj strani.
Olanzapine Glenmark Europe 15 mg orodispersible tablets
Olanzapin Glenmark Europe 15 mg raspadljive tablete za usta
Olanzapine Glenmark Europe 15 mg: yellow coloured circular flat bevelled edge orodispersible tablets with ‘OL’ debossed on one side and ‘5’ debossed on other side.
Olanzapin Glenmark Europe 15 mg: žute, okrugle, plosnate raspadljive tablete za usta kosih rubova, s utisnutom oznakom ‘OL’ na jednoj i ‘5’ na drugoj strani.
Olanzapine Glenmark Europe 20 mg orodispersible tablets
Olanzapin Glenmark Europe 20 mg raspadljive tablete za usta
Olanzapine Glenmark Europe 20 mg: yellow coloured circular flat bevelled edge orodispersible tablets with ‘OL’ debossed on one side and ‘6’ debossed on other side.
Olanzapin Glenmark Europe 20 mg: žute, okrugle, plosnate raspadljive tablete za usta kosih rubova, s utisnutom oznakom ‘OL’ na jednoj i ‘6’ na drugoj strani.
Olanzapine Glenmark Europe 5 mg orodispersible tablets
Olanzapin Glenmark Europe 5 mg raspadljive tablete za usta
Olanzapine Glenmark Europe 5mg is supplied as: yellow coloured circular flat bevelled edge orodispersible tablets with ‘2’ debossed on one side.
Olanzapin Glenmark Europe 5 mg su dostupne kao: žute, okrugle, plosnate raspadljive tablete za usta kosih rubova, s utisnutom oznakom ‘2’ na jednoj strani.
Olanzapine Glenmark Europe contains a source of phenylalanine.
Olanzapin Glenmark Europe sadrži izvor fenilalanina.
Olanzapine Glenmark Europe contains aspartame
Olanzapin Glenmark Europe sadrži aspartam
Olanzapine Glenmark Europe is a ‘generic medicine’.
Olanzapine Glenmark Europe je „generički lijek”.
Olanzapine Glenmark Europe is not for patients who are under 18 years.
Olanzapin Glenmark Europe nije za primjenu u bolesnika mlađih od 18 godina.
Olanzapine Glenmark has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olanzapine treatment.
Pokazalo se da Olanzapin Glenmark sprječava ponavljanje tih simptoma u bolesnika s bipolarnim poremećajem u kojih je epizoda manije reagirala na liječenje olanzapinom.
Olanzapine Glenmark is a ‘generic medicine’.
Olanzapine Glenmark je „generički lijek”.
Olanzapine Glenmark is not for patients who are under 18 years.
Olanzapin Glenmark nije za primjenu u bolesnika mlađih od 18 godina.
Olanzapine Glenmark tablets are for oral use.
Olanzapin Glenmark tablete uzimaju se kroz usta.
Olanzapine Glenmark with alcohol
Olanzapin Glenmark s alkoholom
Olanzapine had no teratogenic effects.
Olanzapin nije imao teratogene učinke
Olanzapine had no teratogenic effects.
Olanzapin nije pokazao teratogene učinke.
Olanzapine is bound predominantly to albumin and α1-acid-glycoprotein.
Olanzapin se prvenstveno veže za albumin i 1-kiseli-glikoprotein.
Olanzapine is bound predominantly to albumin and 1-acid-glycoprotein.
Olanzapin se prvenstveno veže na albumin i 1-kiseli-glikoprotein.
Olanzapine is not approved for the treatment of dementia-related psychosis and/or behavioural disturbances and is not recommended for use in this particular group of patients because of an increase in mortality and the risk of cerebrovascular accident.
Olanzapin nije odobren za liječenje psihoze i/ili poremećaja ponašanja uzrokovanih demencijom te se njegova primjena ne preporučuje u ovoj specifičnoj skupini bolesnika zbog porasta mortaliteta i rizika od pojave cerebrovaskularnog događaja.
Olanzapine is not indicated for the treatment of children and adolescent patients below 18 years.
Olanzapin se ne preporučuje za primjenu u djece i adolescenata mlađih od 18 godina zbog nedostatnih podataka o sigurnosti i djelotvornosti.
Olanzapine is not recommended for use in children and adolescents below 18 years of age due to a lack of data on safety and efficacy.
Olanzapin nije indiciran za liječenje djece i adolescenata mlađih od 18 godina.